Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.

By H. Wertheim, M. Vos, A. Ott, Alex van Belkum, A. Voss, J. Kluytmans, P. V. van Keulen, C. Vandenbroucke-Grauls, M. Meester, H. Verbrugh. The Lancet, 2004

909 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/e533d64102fe2e33bc3a645976d9a4f527249d30

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Foster
2. F. Lowy

In Infectious Diseases

1. Kunyan Zhang
2. Sahreena S. Lakhundi
3. T. Foster
4. F. Lowy
5. R. Gordon

In Molecular Biology

1. Kunyan Zhang
2. Sahreena S. Lakhundi
3. T. Foster
4. F. Lowy
5. R. Gordon

Citations in the corpus

• Pathogenesis of methicillin-resistant Staphylococcus aureus infection. (2008, background): “Because most infections among carriers occurred with their colonizing strains, colonization may confer some protective immunity if staphylococcal infection develops [43].”
• Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, background): “Moreover, in most cases the isolated bloodstream strain belongs to the same genotype as the nasal strain (458, 460, 461).”
• Surface Proteins of Staphylococcus aureus (2019, background): “Approximately 20 to 30% of the population are co-lonized persistently by S. aureus in the nares, with the remainder being intermittently colonized ( 108, 109).”
• Immune evasion by staphylococci (2005, background): “Colonization is a known risk factor for invasive disease both in the hospital and the communit”